We are pleased to announce that yet another Czech company received funds from the prestigious European support program for small and medium enterprises Horizon 2020 SME Instrument.
Who received the funding?
The company is a biotech spin-off of the Masaryk University in Brno (MU) – Enantis. It is developing products for wound healing. It is based on the knowledge received from applied research of proteins. The success at the program is based upon the collaboration with leading scientific representatives from several faculties of MU, and upon support from the South Moravian Innovation Centre.
The product, which the company would like to put on the market is now finished yet. But the European grant of more than 1 mil. EUR should help to transfer the knowledge from research into practise as soon as possible. “We have received funding from the European Union to find a carrier upon which we will be able to apply the growth factor. Preclinical stage is also part of our project. During the testing we will verify the safety and effectivity of our product,” said about the grant the director of Enantis, Veronika Štěpánková. Enantis has already succeeded last year, when it received 1.5 mil. CZK to create a feasibility study.
It is another success for Czech innovative companies. The first company to receive the funding was a start-up Incomaker last year, which specializes in analysing data to improve marketing activities.
We hope that this is not the last time we inform about the successes of Czech companies in the prestigious programs such as Horizon 2020 SME Instrumental.